2025-11-14T14:13:51-06:00 2024-12-31 390974031 WEGNER CPAS LLP 419 N LEE ST ALEXANDRIA VA 223142301 990 2024-01-01 932385426 BLUEPRINT BIOSECURITY BLUE 2929293933 1775 I STREET NW 1150 WASHINGTON DC 20006 JACOB SWETT EXECUTIVE DIRECTOR/BOARD PRESIDENT 2929293933 2025-11-14 1 1 YIGIT UCTUM CPA P01269549 7035190990 2025-11-14 2024 2025-03-06 01:10:19Z JACOB SWETT 1775 I STREET NW 1150 WASHINGTON DC 20006 1832186 0 X BLUEPRINTBIOSECURITY.ORG X 2023 DC TO RESEARCH & ADVANCE INTERVENTIONS TO PREVENT PANDEMICS & ADDRESS BIOLOGICAL THREATS. 4 3 10 6 0 0 2583000 1796943 0 8000 110 26707 2 536 2583112 1832186 0 12500 0 0 389964 1626504 0 0 96940 175564 1456618 565528 3095622 2017584 -1263436 2036040 819848 18456 68649 2017584 751199 X BLUEPRINT BIOSECURITY IS A NONPROFIT THAT CONDUCTS AND SUPPORTS RESEARCH TO IDENTIFY, EVALUATE, AND PROMOTE TECHNICAL COUNTERMEASURES AGAINST EMERGING AIRBORNE PATHOGEN THREATS, HELPING TO PREVENT FUTURE PANDEMICS BY STRENGTHENING READINESS FROM THE FIRST DAY OF AN OUTBREAK. 1 0 1137594 12500 0 FAR-UVC - THE FAR-UVC PROGRAM AIMS TO ACCELERATE WIDESPREAD ADOPTION OF THIS BREAKTHROUGH TECHNOLOGY. THE PROGRAM ADVANCES THE HIGHEST PRIORITY SAFETY, EFFICACY, AND REAL-WORLD EFFECTIVENESS STUDIES, WITH THE ULTIMATE GOALS OF FOSTERING EXPERT CONSENSUS, SECURING ENDORSEMENTS FROM TRUSTED PUBLIC HEALTH BODIES, DEVELOPING REAL-WORLD IMPLEMENTATION GUIDANCE, AND CATALYZING LARGE-SCALE ADOPTION. 573656 0 0 BIOSECURITY, PANDEMIC PREVENTION, AND GOVERNMENT AFFAIRS - THE ORGANIZATION MITIGATES PANDEMIC RISK THROUGH COMPREHENSIVE STAKEHOLDER EDUCATION, STRATEGIC PLANNING, AND COLLABORATIVE PROGRAM EXECUTION ACROSS RESEARCH AND PILOT INITIATIVES. THE ORGANIZATION BUILDS ESSENTIAL NETWORKS WITH KEY PARTNERS TO IMPLEMENT BIOSECURITY MEASURES AND DEVELOP RESILIENT PANDEMIC PREVENTION FRAMEWORKS. THE ORGANIZATION ALSO STRENGTHENS PANDEMIC RESPONSE CAPABILITIES BY ADVOCATING FOR ADVANCED PPE FOR CRITICAL WORKERS IN THE US. 366052 0 0 BUILT ENVIRONMENT TRANSMISSION SUPPRESSION (BETS) - THE ORGANIZATION'S RESEARCH TEAM EVALUATES INTERVENTIONS FOR SUPPRESSING TRANSMISSION OF AIRBORNE PATHOGENS, SUCH AS GLYCOLS. THEY CONDUCT DESKTOP RESEARCH, INTERVIEW LEADING EXPERTS ACROSS A RANGE OF FIELDS, WRITE REPORTS, AND SUGGEST WAYS TO ADVANCE THE DEVELOPMENT OF THE MOST PROMISING OPPORTUNITIES. 321609 0 8000 PERSONAL PROTECTIVE EQUIPMENT (PPE) - THE ORGANIZATION'S RESEARCH HAS IDENTIFIED A CRITICAL GLOBAL SHORTFALL IN HIGH-QUALITY RESPIRATORY PROTECTION NEEDED FOR FUTURE AIRBORNE PANDEMICS. BUILDING ON THESE FINDINGS, THE PPE PROGRAM NOW FOCUSES ON ADVANCING THE STOCKPILING AND MANUFACTURING OF HIGHLY PROTECTIVE REUSABLE RESPIRATORS TO BOLSTER PREPAREDNESS. 321609 0 8000 2398911 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 13 0 10 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA NY X SIOBHAN BRENTON 2929293933 1775 I STREET NW STE 1150 WASHINGTON DC 20006 JACOB SWETT EXECUTIVE DIRECTOR/BOARD PRESIDENT 40.00 X X 250000 0 30913 JASPREET PANNU SECRETARY/TREASURER 1.00 1.00 X X 0 0 0 CHARLIE PETTY DIRECTOR 1.00 1.00 X 0 0 0 CALEB WATNEY DIRECTOR 1.00 X 0 0 0 ANDREW SNYDER-BEATTIE DIRECTOR (THRU OCT) 1.00 1.00 X 0 0 0 DAVID CAREL STRATEGY LEAD 40.00 X 171985 0 39469 CARLY TRYENS EXECUTIVE ASSISTANT 40.00 X 124200 0 36144 RICHARD WILLIAMSON PROGRAM DIRECTOR 40.00 X 181125 0 45106 JAMES MONTAVON FAR-UVC DEPUTY DIRECTOR 40.00 X 103201 0 15799 SIOBHAN BRENTON CHIEF OPERATING OFFICER 40.00 X 191698 0 26351 1022209 0 193782 6 0 1 0 BOOZ ALLEN HAMILTON 4121 WILSON BLVD SUITE 700 ARLINGTON VA 22203 SCIENTIFIC, ENGINEERING, AND TECHNICAL A 296084 GRYPHON SCIENTIFIC 6930 CARROLL AVE STE 810 TAKOMA PARK MD 20912 IDENTIFYING/INVESTIGATING ENVIRONMENTAL 165211 AND-NOW STUDIO 6 SYBIL MEWS LONDON UK N4 1EP GRAPHIC DESIGN AND WEB DEVELOPMENT 102657 3 1796943 1796943 PROGRAM SERVICE FEES 541900 8000 8000 8000 26707 26707 536 536 536 1832186 8000 0 27243 X 12500 12500 280913 238776 14046 28091 1055046 760398 248557 46091 95106 71131 18694 5281 92440 69137 18170 5133 102999 77034 20246 5719 25741 25741 40400 40400 938818 891120 46017 1681 161576 95356 66220 34993 26866 6210 1917 13671 2311 11360 10722 3670 7052 159163 132469 23792 2902 39337 11162 28050 125 5176 510 4666 DUES AND SUBSCRIPTIONS 27021 6471 20550 3095622 2398911 599771 96940 50539 128874 1983095 684343 2406 6631 2036040 819848 18456 68649 18456 68649 X 1702373 624901 315211 126298 2017584 751199 2036040 819848 X -1263436 -2949 X 0 1 X 0 0 X 2583000 1796943 4379943 2583000 1796943 4379943 2401009 1978934 110 26707 26817 4406760 8538 X SCH A, PART II, 2023 COLUMN: THE 2023 COLUMN ON SCHEDULE A, PART II REPRESENTS THE SHORT TAX YEAR BEGINNING JULY 14, 2023 AND ENDING DECEMBER 31, 2023. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 3044 3044 3092578 3095622 304781 76195 0 0 304781 304781 457172 3044 3044 76195 76195 114293 0 1829237 -2949 -2949 1832186 0 1832186 3095622 0 3095622 0 3095622 PART XI, LINE 2D - OTHER ADJUSTMENTS: EXCHANGE LOSS -2,949. NORTH AMERICA 0 1 PROGRAM SERVICES COO SERVICES AND MARKETING 153750 NORTH AMERICA 0 1 MANAGEMENT & GENERAL 37000 NORTH AMERICA 0 1 FUNDRAISING 9250 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES GRAPHIC DESIGN, WEB SERVICES, MARKETING, RESEARCH AND DEVELOPMENT 166554 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 MANAGEMENT & GENERAL 49275 EAST ASIA AND THE PACIFIC 0 4 PROGRAM SERVICES RESEARCH AND DEVLOPMENT, WORKSHOPS 110527 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES RESEARCH AND DEVLOPMENT 280 0 7 0 0 0 7 526636 0 526636 0 0 0 0 0 0 1 JOHNS HOPKINS UNIVERSITY 3910 KESWICK RD N43278 BALTIMORE MD 21211 520595110 501 (C)(3) 12500 0 CENTER FOR HEALTH SECURITY FAR-UVC WORKSHOP SUPPORT. 1 0 PART I, LINE 2: OUR ORGANIZATION MONITORS ITS GRANTS THROUGH STRUCTURED REPORTING, REGULAR CHECK-INS, AND SITE VISITS (WHERE FEASIBLE). GRANTEES MUST SUBMIT NARRATIVE AND FINANCIAL REPORTS AFTER THE GRANT TERM, AND DEPENDING ON THE SIZE AND DURATION OF THE GRANT, WE MAY REQUEST ADDITIONAL MONTHLY, QUARTERLY, OR SEMIANNUAL REPORTS. WE RETAIN THE RIGHT TO REQUEST FURTHER REPORTS AT ANY TIME; FAILURE TO COMPLY CAN RESULT IN WITHHELD PAYMENTS OR TERMINATION. GRANTEES ALSO PARTICIPATE IN PERIODIC CHECK-INS, TYPICALLY SEMIANNUAL BUT SOMETIMES MONTHLY, TO PROVIDE UPDATES ON ACTIVITIES AND FUND USE. ALL FUNDS MUST BE USED SOLELY FOR CHARITABLE PURPOSES IN COMPLIANCE WITH SECTION 170(C)(2)(B) OF THE INTERNAL REVENUE CODE; PROHIBITED USES INCLUDE POLITICAL ACTIVITY, PRIVATE INUREMENT, OR ANY ACTION JEOPARDIZING OUR TAX-EXEMPT STATUS. X X X 0 0 0 0 0 0 0 0 0 JACOB SWETT EXECUTIVE DIRECTOR/BOARD PRESIDENT 250000 0 0 0 0 0 20000 0 10913 0 280913 0 0 0 RICHARD WILLIAMSON PROGRAM DIRECTOR 175000 0 6125 0 0 0 17500 0 27606 0 226231 0 0 0 SIOBHAN BRENTON CHIEF OPERATING OFFICER 185000 0 6698 0 0 0 18500 0 7851 0 218049 0 0 0 DAVID CAREL STRATEGY LEAD 153125 0 18860 0 0 0 15313 0 24156 0 211454 0 0 0 CARLY TRYENS EXECUTIVE ASSISTANT 120000 0 4200 0 0 0 12000 0 24144 0 160344 0 0 0 FORM 990, PART III, LINE 2 DURING THE YEAR THE ORGANIZATION BEGAN THE PPE PROGRAM. PERSONAL PROTECTIVE EQUIPMENT (PPE) - THE ORGANIZATION'S RESEARCH HAS IDENTIFIED A CRITICAL GLOBAL SHORTFALL IN HIGH-QUALITY RESPIRATORY PROTECTION NEEDED FOR FUTURE AIRBORNE PANDEMICS. BUILDING ON THESE FINDINGS, THE PPE PROGRAM NOW FOCUSES ON ADVANCING THE STOCKPILING AND MANUFACTURING OF HIGHLY PROTECTIVE REUSABLE RESPIRATORS TO BOLSTER PREPAREDNESS. FORM 990, PART VI, SECTION B, LINE 11B CHIEF OPERATING OFFICER WILL REVIEW FORM 990, AFTER WHICH A DRAFT WILL BE DISTRIBUTED TO BOARD MEMBERS WITH DETAILED DESCRIPTIONS EXPLAINING FORM 990, OPPORTUNITIES FOR QUESTIONS AND CONSULTATIONS WILL BE PROVIDED TO ALL BOARD MEMBERS BEFORE SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C AN INTERESTED PERSON MUST DISCLOSE IN WRITING THE EXISTENCE OF AN ACTUAL, PERCEIVED, OR POTENTIAL CONFLICT OF INTEREST, WHETHER FINANCIAL OR OTHERWISE. THE INTERESTED PERSON WILL BE GIVEN THE OPPORTUNITY TO DISCLOSE IN WRITING ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. IF THE INTERESTED PERSON INVOLVED DOES NOT MAKE THIS DISCLOSURE, ANOTHER DIRECTOR, COMMITTEE MEMBER, OR EMPLOYEE WITH KNOWLEDGE OF THE ACTUAL, PERCEIVED, OR POTENTIAL CONFLICT SHOULD DRAW IT TO THE APPROPRIATE BODY'S ATTENTION. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST: AFTER DISCLOSURE OF THE ACTUAL, PERCEIVED, OR POTENTIAL CONFLICT AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, S/HE SHALL LEAVE THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS; IF IT IS DETERMINED THAT A CONFLICT OF INTEREST EXISTS, THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT; AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST; IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE ORGANIZATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT; IN THE CASE OF DISCLOSURES OF ALTERNATE BOARD OR OFFICER POSITIONS, THE BOARD OF DIRECTORS MAY, FOLLOWING SUCH DISCLOSURE, TAKE SUCH ACTION AS MAY BE NECESSARY TO PRESERVE THE INDEPENDENCE OF THE ORGANIZATION, INCLUDING BY SEEKING THE RESIGNATION OF THE DIRECTOR OR OFFICER. FORM 990, PART VI, SECTION B, LINE 15A THE PROCESS TO ESTABLISH COMPENSATION INVOLVED RESEARCHING VARIOUS SOURCES, INCLUDING PUBLIC 990 TAX RETURNS, DATA FROM THINK TANKS AND FOUNDATIONS, THIRD-PARTY BENCHMARKING STUDIES, AND SALARY RANGES FROM PUBLICLY AVAILABLE JOB ADS AND PLATFORMS SUCH AS GLASSDOOR, ALL WHILE CONSIDERING THE FACTORS OF LOCATION AND ORGANIZATION SIZE. BASED ON THIS RESEARCH, THE BOARD MADE THE FINAL DECISION TO SET COMPENSATION FOR SPECIFIC ROLES, ALIGNING THEIR DECISION WITH THE COLLECTED INDUSTRY DATA AND ENSURING CONSISTENCY WITH THE ORGANIZATION'S COMPENSATION STRUCTURE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G HONORARIUMS: PROGRAM SERVICE EXPENSES 15,288. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 15,288. OPERATIONS CONSULTANT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 40,066. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 40,066. GENERAL CONTRACTORS: PROGRAM SERVICE EXPENSES 185,965. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 185,965. SME CONTRACTORS: PROGRAM SERVICE EXPENSES 570,815. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 570,815. SRA CONTRACTORS: PROGRAM SERVICE EXPENSES 96,410. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 96,410. PAYROLL SERVICE FEES: PROGRAM SERVICE EXPENSES 22,642. MANAGEMENT AND GENERAL EXPENSES 5,951. FUNDRAISING EXPENSES 1,681. TOTAL EXPENSES 30,274. FORM 990, PART XI, LINE 9: EXCHANGE LOSS -2,949. MIRROR BIOLOGY DIALOGUES FUND 500 5TH AVE NEW YORK CITY NY 10110 993886393 TO ADVANCE AND SUPPORT THE GLOBAL EFFORT TO UNDERSTAND AND ADDRESS RISKS NY 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0